On April 26, 2026, Sun Pharmaceutical Industries Limited (“Sun Pharma”) and Organon & Co. (“Organon”) announced an agreement for Sun Pharma to ...
MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or ...
Shares of Organon & Co surged on Friday after a report that Sun Pharmaceutical Industries plans to increase its binding offer for the women’s healthcare company to $13 billion. Earlier this month, Sun ...
Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (“Organon”) announced that they have entered into a definitive ...
After intense negotiations, Sun Pharma is set to acquire Organon for $11.75 billion, marking a significant milestone for Indian overseas acquisitions. The deal aims to strengthen Sun Pharma's global ...
Sun Pharmaceutical Industries will buy U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion ...
Sun Pharmaceutical Industries Ltd will acquire US-based Organon & Co in an all-cash deal at an enterprise valuation of USD 11.75 billion in one of the largest acquisitions by Indian firms overseas.
Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion ...
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results